Being overweight or obese is an important cause of rising cancer rates among younger adults in England, according to a major new study. Researchers at The Institute of Cancer Research, London, and ...

Scientists have developed an AI-powered method that could determine which patients with advanced bowel cancer are most likely to respond to a targeted drug used on the NHS – potentially sparing ...

Scientists have created the most comprehensive map to date of the genetic mutations that fuel cancer – opening the door to extending precision treatments to thousands more patients and offering clues ...

In this feature, cancer scientists and animal research experts across The Institute of Cancer Research, London, discuss why breakthroughs gained by studying whole-body systems in animals are essential ...

A team of scientists at The Institute of Cancer Research, London, has developed a repeatable three-dimensional (3D) imaging technique that could transform preclinical cancer studies. The researchers ...

The Institute of Cancer Research, London, works closely with trusts, foundations and charity partners who play an important part in enabling our state-of-the-art research. We recently marked a ...

As we enter 2026, scientists at The Institute of Cancer Research, London, share the developments expected this year that could soon change how cancer is treated – from technologies designed to deliver ...

The Institute of Cancer Research, London, is the joint recipient of a major new Medical Research Council (MRC) grant to advance how sensitive medical imaging data can be used for research. This award ...

The Institute of Cancer Research, London, welcomes the decision by the National Institute for Health and Care Excellence (NICE) to recommend the targeted drug talazoparib (trade name Talzenna), in ...

A blood test can predict how well patients with advanced breast cancer will respond to targeted therapies – before treatment begins, according to new research. A team from The Institute of Cancer ...

The Institute of Cancer Research, London has welcomed the announcement by NHS England that the lifesaving drug abiraterone has been approved for use on the NHS for men in England with prostate cancer ...

Tens of thousands of tumour samples which have been stored in the basement of a London hospital for more than 70 years could be the key to unlocking the mystery of why bowel cancer cases are rising in ...